J&J May Continue Divestiture Trend With $2B Cordis Offer
Cardinal Health Inc. has offered to buy Johnson & Johnson's vascular technology unit for nearly $2 billion, the companies said Monday, as J&J continues its plan of divesting noncore divisions in...To view the full article, register now.
Already a subscriber? Click here to view full article